<SEC-DOCUMENT>0001193125-24-279907.txt : 20241217
<SEC-HEADER>0001193125-24-279907.hdr.sgml : 20241217
<ACCEPTANCE-DATETIME>20241216201700
ACCESSION NUMBER:		0001193125-24-279907
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20241216
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241217
DATE AS OF CHANGE:		20241216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		241553366

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d882067d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20241216" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-12-16_to_2024-12-16">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-278">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-12-16_to_2024-12-16">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cvs-20241216.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-12-16_to_2024-12-16"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-12-16</xbrli:startDate> <xbrli:endDate>2024-12-16</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-289">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt:datemonthdayyearen" id="ixv-290">December 16, 2024</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g882067g1216211413548.jpg" alt="LOGO" style="width:1.10972in;height:0.211806in"/></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:stateprovnameen" id="ixv-291">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-292">001-01011</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-293">05-0494040</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-294">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-295">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:stateprovnameen" id="ixv-296">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-297">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-298">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-299">765-1500</ix:nonNumeric></span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:boolballotbox" id="ixv-300">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:boolballotbox" id="ixv-301">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:boolballotbox" id="ixv-302">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:boolballotbox" id="ixv-303">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-304">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-305">CVS</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:exchnameen" id="ixv-306">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-12-16_to_2024-12-16" format="ixt-sec:boolballotbox" id="ixv-307">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;8.01. Other Events </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;16, 2024, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221;), issued press releases announcing the (A)&#160;early results and election of early settlement and (B)&#160;pricing, respectively, of its cash tender offer (the &#8220;Maximum Tender Offer&#8221;) for the maximum principal amount of the following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not including accrued interest, payable in respect of such Maximum Tender Offer Notes, does not exceed $1,774,423,242.62 (such maximum purchase price, the &#8220;Maximum Tender Offer Amount&#8221;): its 2.700% Senior Notes due 2040, its 3.875% Senior Notes due 2047 issued by its wholly-owned subsidiary Aetna Inc. (&#8220;Aetna&#8221;), its 4.250% Senior Notes due 2050, the 4.125% Senior Notes due 2042 issued by Aetna, its 4.125% Senior Notes due 2040, its 2.125% Senior Notes due 2031, its 1.875% Senior Notes due 2031, its 5.050% Senior Notes due 2048, the 4.500% Senior Notes due 2042 issued by Aetna and its 1.750% Senior Notes due 2030 (together, the &#8220;Maximum Tender Offer Notes&#8221;) validly tendered and accepted for purchase in connection with the Company&#8217;s previously announced cash tender offer commenced on December&#160;2, 2024. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because the Company expects to accept for purchase, subject to proration, the Maximum Tender Offer Amount of the Maximum Tender Offer Notes, no additional Maximum Tender Offer Notes are expected to be purchased pursuant to the Maximum Tender Offer after December&#160;18, 2024, the early settlement date for such Maximum Tender Offer Notes validly tendered and accepted for purchase by the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the press releases are attached hereto as Exhibits 99.1 and 99.2, which are incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Information Regarding Forward Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of the Company. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in the Company&#8217;s Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in the Company&#8217;s most recently filed Annual Report on Form <span style="white-space:nowrap">10-K,</span> Quarterly Reports on Form <span style="white-space:nowrap">10-Q</span> for the quarterly periods ended March&#160;31, 2024, June&#160;30, 2024 and September&#160;30, 2024 and Current Reports on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on the Company&#8217;s forward-looking statements. The Company&#8217;s forward-looking statements are and will be based upon management&#8217;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. The Company does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;9 - Financial Statements and Exhibits </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Item&#8201;9.01 Financial Statements and Exhibits. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) <span style="text-decoration:underline">Exhibits</span>. </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:94%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"><span style="font-weight:bold">99.1</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold"><a href="d882067dex991.htm">Early Tender Results Press Release of CVS Health Corporation dated December&#160;16, 2024 </a></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"><span style="font-weight:bold">99.2</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold"><a href="d882067dex992.htm">Pricing Press Release of CVS Health Corporation dated December&#160;16, 2024 </a></span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap"><span style="font-weight:bold">104</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="font-weight:bold">Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).</span></td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December&#160;16, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas F. Cowhey</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Thomas F. Cowhey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d882067dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g882067g1214092329823.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Larry McGrath</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Media</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ethan Slavin</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">860-273-6095</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Strategy Officer&nbsp;&amp; Chief Strategic</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Advisor to the CEO <BR>investorinfo@cvshealth.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ethan.Slavin@CVSHealth.com</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Corporation Announces Early Results of Maximum Tender Offer and Election of Early Settlement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI, December&nbsp;16, 2024&#150; CVS Health Corporation (&#147;CVS Health&#148; or the &#147;Company,&#148; NYSE: CVS) announced today the early
results of the previously announced cash tender offer (the &#147;Maximum Tender Offer&#148;) for the maximum principal amount of the following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not
including Accrued Interest (as defined below), payable in respect of such Maximum Tender Offer Notes, does not exceed $1,774,423,242.62 (such maximum purchase price, the &#147;Maximum Tender Offer Amount&#148;): its 2.700% Senior Notes due 2040, the
3.875% Senior Notes due 2047 issued by its wholly-owned subsidiary Aetna Inc. (&#147;Aetna&#148;), its 4.250% Senior Notes due 2050, the 4.125% Senior Notes due 2042 issued by Aetna, its 4.125% Senior Notes due 2040, its 2.125% Senior Notes due
2031, its 1.875% Senior Notes due 2031, its 5.050% Senior Notes due 2048, the 4.500% Senior Notes due 2042 issued by Aetna and its 1.750% Senior Notes due 2030 (together, the &#147;Maximum Tender Offer Notes&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of 5:00 p.m., New York City time, on December&nbsp;13, 2024 (the &#147;Early Tender Date&#148;), as reported by D.F. King&nbsp;&amp; Co., Inc., the Tender
and Information Agent for the Maximum Tender Offer, the principal amounts of the Maximum Tender Offer Notes listed in the tables below have been validly tendered and not validly withdrawn. The Maximum Tender Offer Withdrawal Deadline of 5:00 p.m.,
New York City time, on December&nbsp;13, 2024 has passed and, accordingly, Maximum Tender Offer Notes validly tendered in the Maximum Tender Offer may no longer be withdrawn. The Maximum Tender Offer was made pursuant to the terms and conditions set
forth in the Offer to Purchase dated December&nbsp;2, 2024 (as amended or supplemented from time to time, the &#147;Offer to Purchase&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health
announced its election, with respect to the Maximum Tender Offer Notes validly tendered and not validly withdrawn at or prior to the Early Tender Date, to accept for purchase and make payment for such Maximum Tender Offer Notes on December&nbsp;18,
2024 (the &#147;Early Settlement Date&#148;), subject to the acceptance priority levels applicable to the relevant series as described in the Offer to Purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because CVS Health expects to accept for purchase, subject to proration, the Maximum Tender Offer Amount of the Maximum Tender Offer Notes, no additional
Maximum Tender Offer Notes are expected to be purchased pursuant to the Maximum Tender Offer after the Early Settlement Date. As described in the Offer to Purchase, Maximum Tender Offer Notes tendered and not accepted for purchase will be promptly
returned to the tendering Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total consideration (the &#147;Total Consideration&#148;) payable by CVS Health for the Maximum Tender Offer Notes
will be a price per $1,000 principal amount calculated as described in the Offer to Purchase in a manner intended to result in a yield to maturity or first par call date, as the case may be, equal to the sum of the yield to maturity of the
applicable U.S. Treasury reference security specified in the table below as determined at 10:00 a.m., New York City time, on December&nbsp;16, 2024 and the fixed spread shown in the table below. Holders of all Maximum Tender Offer Notes that were
validly tendered and not validly withdrawn at or prior to the Early Tender Date and that are accepted for purchase will receive the applicable Total Consideration, which includes the applicable Early Tender Payment of $30 per $1,000 principal amount
of Maximum Tender Offer Notes tendered at or prior to the Early Tender Date. In addition to the applicable Total Consideration, Holders of Maximum Tender Offer Notes accepted for purchase will receive accrued and unpaid interest (&#147;Accrued
Interest&#148;) on those Maximum Tender Offer Notes from the last interest payment date with respect to those Maximum Tender Offer Notes to, but not including, the Early Settlement Date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Maximum Tender Offer Notes</I></B><B>: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Title of Notes</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>CUSIP<BR>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Original<BR>Issuer</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal<BR>Amount<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Maturity<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Acceptance<BR>Priority<BR>Level<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>UST<BR>Reference<BR>Security</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bloomberg<BR>Reference<BR>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fixed<BR>Spread<BR>(bps)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal<BR>Amount<BR>Tendered</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent<BR>Tendered</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">2.700% Senior Notes due 2040</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DP2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8/21/2040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.625%&nbsp;due<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:9pt; font-family:Times New Roman">11/15/2044</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+110&nbsp;bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">882,639,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70.61</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">3.875% Senior Notes due 2047</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>00817YAZ1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Aetna Inc.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8/15/2047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.625%&nbsp;due<BR>11/15/2044</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+121 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">463,035,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46.30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">4.250% Senior Notes due 2050</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DL1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/1/2050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.250%&nbsp;due<BR>8/15/2054</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+136 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,530,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46.74</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">4.125% Senior Notes due 2042</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>00817YAM0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Aetna Inc.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/15/2042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">4</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.625%&nbsp;due<BR>11/15/2044</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+122 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">274,315,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54.86</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">4.125% Senior Notes due 2040</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DK3</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4/1/2040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.625%&nbsp;due<BR>11/15/2044</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+119 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">692,302,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69.23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">2.125% Senior Notes due 2031</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DR8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9/15/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.250%&nbsp;due<BR>11/15/2034</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+92 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">406,793,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40.68</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">1.875% Senior Notes due 2031</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DQ0</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/28/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.250%&nbsp;due<BR>11/15/2034</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+87 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">514,191,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41.14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">5.050% Senior Notes due 2048</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650CZ1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,000,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/25/2048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">8</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.250%&nbsp;due<BR>8/15/2054</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+156 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,202,676,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15.03</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">4.500% Senior Notes due 2042</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>00817YAJ7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Aetna Inc.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/15/2042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">9</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.625%&nbsp;due<BR>11/15/2044</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+130 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">93,121,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.62</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">1.750% Senior Notes due 2030</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>126650DN7</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CVS Health<BR>Corporation</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8/21/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>4.125%&nbsp;due<BR>11/30/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">FIT1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">+106 bps</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">182,059,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14.56</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to amend, extend or terminate the Maximum Tender Offer with respect
to any or all series of Maximum Tender Offer Notes at any time if any condition to the Maximum Tender Offer is not satisfied. The Maximum Tender Offer is not conditioned on any minimum principal amount of Maximum Tender Offer Notes being tendered
but the Maximum Tender Offer is subject to certain other general conditions as described in the Offer to Purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health has retained Barclays
Capital Inc. and Mizuho Securities USA LLC to act as Dealer Managers for the Maximum Tender Offer. D.F. King&nbsp;&amp; Co., Inc. has been retained to act as the Tender and Information Agent for the Maximum Tender Offer. The Offer to Purchase may be
accessed at the following link: http://www.dfking.com/cvs. Requests for assistance relating to the procedures for tendering Maximum Tender Offer Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone
(212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (for banks and brokers only) or (800) <FONT STYLE="white-space:nowrap">487-4870</FONT> (for all others toll free). Requests for assistance relating to the terms and conditions of the Maximum
Tender Offer may be directed to Barclays Capital Inc. at (800) <FONT STYLE="white-space:nowrap">438-3242</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">528-7581</FONT> (collect) or Mizuho Securities USA LLC at (866) <FONT
STYLE="white-space:nowrap">271-7403</FONT> (toll-free) or (212) <FONT STYLE="white-space:nowrap">205-7741.</FONT> Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with
respect to, any securities, including the Maximum Tender Offer Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Maximum Tender Offer is being made
solely pursuant to the Offer to Purchase made available to Holders of the Maximum Tender Offer Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Maximum Tender Offer Notes, or any of
their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of their Maximum Tender Offer Notes in response to the Maximum Tender Offer. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax
advisers and make their own decisions whether to tender Maximum Tender Offer Notes in the Maximum Tender Offer, and, if so, the principal amount of Maximum Tender Offer Notes to tender. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health is a leading health
solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of September&nbsp;30, 2024, the Company had more than 9,000 retail locations, more than 900 <FONT
STYLE="white-space:nowrap">walk-in</FONT> medical clinics, more than 225 primary care medical clinics, a leading pharmacy benefits manager with approximately 90&nbsp;million plan members and expanding specialty pharmacy solutions, and a dedicated
senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36&nbsp;million people through traditional, voluntary and consumer-directed health insurance products and related services,
including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven
care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health. By their nature, all forward-looking statements are not guarantees of future
performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties
described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading &#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in our most recently filed Annual Report
on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly periods ended March&nbsp;31, 2024, June&nbsp;30, 2024 and September&nbsp;30, 2024 and our Current
Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on CVS Health&#146;s forward-looking
statements. CVS Health&#146;s forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements.
CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d882067dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g882067g03a53.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Larry McGrath</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Media</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ethan Slavin</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Contact:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">860-273-6095</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Strategy Officer&nbsp;&amp; <BR>Chief&nbsp;Strategic&nbsp;Advisor&nbsp;to&nbsp;the&nbsp;CEO</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">investorinfo@cvshealth.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ethan.Slavin@CVSHealth.com</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR IMMEDIATE RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS Health Corporation Announces Pricing of Maximum Tender Offer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WOONSOCKET, RI, December&nbsp;16, 2024 &#150; CVS Health Corporation (&#147;CVS Health&#148; or the &#147;Company,&#148; NYSE: CVS) announced today the
applicable Reference Yields and Total Consideration (each as summarized in the tables below) to be paid in connection with the previously announced cash tender offer (the &#147;Maximum Tender Offer&#148; ) for the maximum principal amount of the
following series of Maximum Tender Offer Notes (as defined below) for which the aggregate purchase price, not including Accrued Interest (as defined below), payable in respect of such Maximum Tender Offer Notes, does not exceed $1,774,423,242.62
(such maximum purchase price, the &#147;Maximum Tender Offer Amount&#148;): its 2.700% Senior Notes due 2040, the 3.875% Senior Notes due 2047 issued by its wholly-owned subsidiary Aetna Inc. (&#147;Aetna&#148;), its 4.250% Senior Notes due 2050,
the 4.125% Senior Notes due 2042 issued by Aetna, its 4.125% Senior Notes due 2040, its 2.125% Senior Notes due 2031, its 1.875% Senior Notes due 2031, its 5.050% Senior Notes due 2048, the 4.500% Senior Notes due 2042 issued by Aetna and its 1.750%
Senior Notes due 2030 (together, the &#147;Maximum Tender Offer Notes&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The applicable Reference Yield for the Maximum Tender Offer Notes and the
Total Consideration for the Maximum Tender Offer Notes are summarized in the table below: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Maximum Tender Offer Notes</I></B><B>: </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Title of Notes</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>CUSIP<BR>Number</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Original<BR>Issuer</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Principal<BR>Amount<BR>Outstanding</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Maturity<BR>Date</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Acceptance&#8194;<BR>Priority<BR>&#8194;&nbsp;
Level<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&#8194;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>UST<BR>Reference<BR>Security</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Bloomberg<BR>Reference<BR>Page</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Fixed<BR>Spread<BR>(bps)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Early&#8194;<BR>Tender&#8194;<BR>Payment<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&#8194;</B></TD>

<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Reference&#8194;<BR>Yield<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&#8194;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Total<BR>Consideration<SUP STYLE="font-size:75%; vertical-align:top">(2)(3)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>&#8194;Approximate&#8194;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proration<BR>Factor<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">2.700% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes&nbsp;due&nbsp;2040</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DP2&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,250,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">8/21/2040&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.625%&nbsp;due&#8201;<BR>11/15/2044&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+110&nbsp;bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.676%&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$685.54&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">100%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">3.875% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2047</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">00817YAZ1&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">Aetna Inc.&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,000,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">8/15/2047&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">2</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.625% due&#8201;<BR>11/15/2044&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+121 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.676%&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$750.06&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">100%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">4.250% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2050</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DL1&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$750,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4/1/2050&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">3</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.250% due&#8201;<BR>8/15/2054&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+136 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.611%&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$776.80&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">100%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">4.125% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2042</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">00817YAM0&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">Aetna Inc.&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$500,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">11/15/2042&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">4</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.625% due&#8201;<BR>11/15/2044&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+122 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.676%&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$805.69&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">100%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">4.125% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2040</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DK3&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,000,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4/1/2040&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">5</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.625% due&#8201;<BR>11/15/2044&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+119 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.676%&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$825.77&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">57.5%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">2.125% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2031</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DR8&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,000,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">9/15/2031&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">6</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.250% due&#8201;<BR>11/15/2034&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+92 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">1.875% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2031</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DQ0&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,250,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">2/28/2031&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">7</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.250% due&#8201;<BR>11/15/2034&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+87 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">5.050% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2048</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650CZ1&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$8,000,000,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">3/25/2048&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">8</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.250% due&#8201;<BR>8/15/2054&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+156 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">4.500% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2042</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">00817YAJ7&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">Aetna Inc.&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$500,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">5/15/2042&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">9</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.625% due&#8201;<BR>11/15/2044&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+130 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">1.750% Senior</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Notes due 2030</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">126650DN7&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">CVS&nbsp;Health&#8201;<BR>Corporation&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$1,250,000,000&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">8/21/2030&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">10</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">4.125% due&#8201;<BR>11/30/2029&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">FIT1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">+106 bps&#8201;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">$30</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">N/A</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">0%</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Subject to each of the Maximum Tender Offer Amount and proration, the principal amount of each series of Maximum
Tender Offer Notes that is purchased in the Maximum Tender Offer will be determined in accordance with the applicable acceptance priority level (in numerical priority order) specified in this column. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Per $1,000 principal amount of Maximum Tender Offer Notes validly tendered at or prior to the Early Tender Date
(as defined below) and accepted for purchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Pricing information has only been provided for the Maximum Tender Offer Notes that are expected to be fully or
partially accepted for tender. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">The proration factor has been rounded to the nearest tenth of a percentage point for presentation purposes.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Maximum Tender Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated
December&nbsp;2, 2024 (as it may be amended or supplemented from time to time, the &#147;Offer to Purchase&#148;), which sets forth a more detailed description of the Maximum Tender Offer. Copies of the Offer to Purchase are available at
www.dfking.com/cvs. The Maximum Tender Offer is open to all registered holders (individually, a &#147;Holder&#148; and collectively, the &#147;Holders&#148;) of the Maximum Tender Offer Notes. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Total Consideration payable by CVS Health for the Maximum Tender Offer Notes is a price per $1,000
principal amount calculated as described in the Offer to Purchase in a manner intended to result in a yield to maturity or first par call date, as the case may be, equal to the sum of the yield to maturity of the applicable U.S. Treasury reference
security specified in the table above as determined at 10:00 a.m., New York City time, on December&nbsp;16, 2024 and the applicable fixed spread shown in the table above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maximum Tender Offer Notes that were tendered and not validly withdrawn at or prior to 5:00 p.m., New York City time, on December&nbsp;13, 2024 (the
&#147;Early Tender Date&#148;) and that are accepted for purchase will receive the applicable Total Consideration, which includes the Early Tender Payment (as defined in the Offer to Purchase). Maximum Tender Offer Notes that are tendered after the
Early Tender Date but at or prior to 5:00 p.m., New York City time, on December&nbsp;31, 2024 (the &#147;Maximum Tender Offer Expiration Date&#148;) (unless earlier terminated by CVS Health as described in the Offer to Purchase) and that are not
validly withdrawn and that are accepted for purchase will receive only the applicable Tender Offer Consideration (as defined in the Offer to Purchase), which is the applicable Total Consideration minus the Early Tender Payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Maximum Tender Offer Withdrawal Deadline of 5:00 p.m., New York City time, on December&nbsp;13, 2024 has passed and, accordingly, Maximum Tender Offer
Notes validly tendered in the Maximum Tender Offer may no longer be withdrawn. The settlement date for the Maximum Tender Offer Notes validly tendered at or prior to the Early Tender Date and accepted for purchase is expected to be December&nbsp;18,
2024, the third business day after the Early Tender Date (the &#147;Early Settlement Date&#148;). Although the Maximum Tender Offers is scheduled to expire at 5:00 p.m., New York City time, on December&nbsp;31, 2024, unless extended or terminated,
because the aggregate purchase price of Notes validly tendered (and not validly withdrawn) prior to the Early Tender Date exceeded the Maximum Tender Offer Amount, there is not expected to be a Final Settlement Date (as defined in the Offer to
Purchase), and no Notes tendered after the Early Tender Date are expected to be accepted for purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the Total Consideration for the
Maximum Tender Offer Notes, Holders of the Maximum Tender Offer Notes accepted for purchase on the Early Settlement Date will receive accrued and unpaid interest (&#147;Accrued Interest&#148;) on those Maximum Tender Offer Notes from the last
interest payment date with respect to those Maximum Tender Offer Notes to, but not including, the Early Settlement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health expressly reserves
the right, in its sole discretion, subject to applicable law, to amend, extend or terminate the Maximum Tender Offer with respect to any or all series of Maximum Tender Offer Notes at any time if any condition to the Maximum Tender Offer is not
satisfied. The Maximum Tender Offer is not conditioned on any minimum principal amount of Maximum Tender Offer Notes being tendered but the Maximum Tender Offer is subject to certain other general conditions as described in the Offer to Purchase.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health has retained Barclays Capital Inc. and Mizuho Securities USA LLC to act as Dealer Managers for the Maximum Tender Offer. D.F. King&nbsp;&amp;
Co., Inc. has been retained to act as the Tender and Information Agent for the Maximum Tender Offer. The Offer to Purchase may be accessed at the following link: http://www.dfking.com/cvs. Requests for assistance relating to the procedures for
tendering Maximum Tender Notes may be directed to the Tender and Information Agent either by email at cvs@dfking.com, or by phone (212) <FONT STYLE="white-space:nowrap">269-5550</FONT> (for banks and brokers only) or (800) <FONT
STYLE="white-space:nowrap">487-4870</FONT> (for all others toll free). Requests for assistance relating to the terms and conditions of the Maximum Tender Offer may be directed to Barclays Capital Inc. at (800)
<FONT STYLE="white-space:nowrap">438-3242</FONT> (toll free) or (212) <FONT STYLE="white-space:nowrap">528-7581</FONT> (collect) or Mizuho Securities USA LLC at (866) <FONT STYLE="white-space:nowrap">271-7403</FONT> (toll-free) or (212) <FONT
STYLE="white-space:nowrap">205-7741.</FONT> Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with
respect to, any securities, including the Maximum Tender Offer Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Maximum Tender Offer is being made
solely pursuant to the Offer to Purchase made available to Holders of the Maximum Tender Offer Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Maximum Tender Offer Notes, or any of
their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Maximum Tender Offer Notes in response to the Maximum Tender Offer. Holders are urged to
evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Maximum Tender Offer Notes in the Maximum Tender Offer, and, if so, the principal amount of
Maximum Tender Offer Notes to tender. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CVS Health </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CVS Health is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people
wherever they are. As of September&nbsp;30, 2024, the Company had more than 9,000 retail locations, more than 900 <FONT STYLE="white-space:nowrap">walk-in</FONT> medical clinics, more than 225 primary care medical clinics, a leading pharmacy
benefits manager with approximately 90&nbsp;million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than
36&nbsp;million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company
is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall
health care costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health. By their nature, all forward-looking statements are not
guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and
uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading &#147;Cautionary Statement Concerning Forward-Looking Statements&#148; in our most recently filed
Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly periods ended March&nbsp;31, 2024, June&nbsp;30, 2024 and September&nbsp;30, 2024 and
our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You are cautioned not to place undue reliance on CVS Health&#146;s
forward-looking statements. CVS Health&#146;s forward-looking statements are and will be based upon management&#146;s then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of
such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cvs-20241216.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/17/2024 6:09:52 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2024"
  xmlns:cvs="http://www.cvshealth.com/20241216"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20241216"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" namespace="http://xbrl.sec.gov/naics/2024" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20241216_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20241216_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cvs-20241216_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/17/2024 6:09:52 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cvs-20241216_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241122.1 -->
<!-- Creation date: 12/17/2024 6:09:52 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20241216.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g882067g03a53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g882067g03a53.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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MZX\W1]+NDVMKTJGB653C%NO;N[*>JD"M3_@G_P#\$ O&6O?M*:A)\9M%FLO
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(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g882067g1214092329823.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g882067g1214092329823.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  = -D# 2(  A$! Q$!_\0
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MV_CSQ[<>)KLVMFSPZ9']U<E3*?5O;T%7_A[\09-$N$TW5I2^G2'"2,<F _\
MQ'\J\YSSQ6AH^C7NO:G'I]C%OFD/)/W47NS'L!2A5J2J<RW'7R_"PPCI25HK
MK^I]'^*?$MOX:T"74W D8X$2 _?8]!GT[_05\^:GXAUWQ+>_Z3=3S/*V$MH<
M[![!!_\ KKN/BXCZ?I7A[2A(72&-LL?XBJJH/ZG\ZB^"]E%/K>H7<BAGMX56
M/(Z;B<D?@,?C735<JE14[V1XV7TZ6$P<L8U=]/OL<'_Q._#MPA/V[3I6^9<Y
MCW?XUT^I^+]4\0^$XYVO)X;[3I )C!(R"6-^ Q"D#(( /IGWKV/Q3X4L?%6G
MQVEV[QB.0.DD6-P.",<@\<US$?PFT[3['4!:WEU+)<VKPA967:"<$'@#H0*/
M83BVHO0G^UL-B%&=:-II]CEOA+K]Y)XJDL;R\GF6Y@.P32E\,O/&3Z9K<^,6
MNW%E;Z;86ES+!)([2NT4A1MH& ,CMD_I7EWAB_?1O%FG7390PW"K(/0$[6_0
MFMKXGZD=2\;W05LQVJ+ N/4#+?J3^50JC5%KK<ZYX&,LRC-+W;7^X-!\4:MH
MNDWVK&^N9I7(M+99IF=%8_,S;2<$@ 8^M8\$&O\ BV^D2(W6HSCYFW2=!^)P
M*[B^\$W;_"G2Y+2!I+M'^US1J/F8.#T'<@;>/8UP&CZYJ7AZ\:XTZX:"8C:P
M9001Z$&LYIJRG>QTX65.I[2IATN>[6OD6K35M?\ "FIM&EQ<6D\#?/;RD[#W
MP0>"#_\ JKVR51\1/ MM+!J-[I9EQ*TEG)M<%<ADSZ9S^0KSW3OBA%-<J_B#
M0;*[S@-/%&-X'T;.?S%>PZ5=:;>Z$ESI7E"TDC+((E"CGKP.ASUKJPUKNSNN
MQX6=.HU%U:7++NMF>4? W3]0U:&;Q%?>(=5N6MKB2V%I-<,\3#:OS$$]?FKU
M+Q5H+>)-%:Q74[W32'$GGV4FR3C/&?0UXA\)O%^L^'_#5[:Z=X/U+68GOGD-
MQ;-A5.U1M^Z>> ?QKO'^)GB@HP/PRUP9!YW_ /V%=9\^8/P,T_4-7MY?$=_X
MAU6Y:WGDMA:S7#/$PVK\Q!)YYKV^O&_@%<Q6?PXU2ZN'\N&&^EDD8_PJ(T)/
MY5#I$7BGXM-<ZN^N7NA>'!*R6=O9';+,%."68'_$9R .* /:J*\2UNW\5?".
M2#6X-?O-<\/>:$O+6^;=)&&.,JQ/ZC'.,@YKI/B)X]N=(TC2;7PV!/J^NNJV
M)(R%5L?/@_[R@9XYSVH ])HKR2W^%/B4P"]N?B%K"ZR1NW1NQ@4^FTGD?E]*
MY*SO_'?B/XH'PMJGB*[TBYM8"LK61.R4H,B0+D#Y@0?Z=J -O4+*_P##OQVT
M"UBU[5;FUU)I;F2WGN6,:9\SY O3:,# ]J]"\3^-(/#.NZ#I<MG+,^L7'D)(
MC@",Y49(/7[WZ5Q?C/\ Y.!\#_\ 7N__ +4KG/BCX;U2/XA>&F?Q->N-3U%O
MLH*_\>&73_5\\XR/3H* /0/BWI=Q<^#[C5;;5]0L)=,ADF5;.8H)B<</CJ!C
M]36K\-;B:[^'.A7%Q-)/-); O)*Q9F.3R2>36)XHT:]T+X-^(++4-8N=6F%O
M(_VFX&&P<87J>!7'^ O!WB/QAX)TVXO_ !/?:5ID47E6=IIQ\LLJDC>YSR2<
M_P#UJ />**\@\.:CX@\#?$6V\':]JLNKZ;J,1>PNY_\ 6(PS\I))/8C&3U!&
M,D5Z_0!@>)O#5CXFTM[*\7!^]'(H^:-NQ'^'>OG/7M!O/#>J26-ZI#KRD@'R
MRKV(_P \5]4CD"N9\:>&K'Q'HLD5T-LL0+PS*/F0@?J#W%<V(HJ:OU/9RG,Y
MX2?)+6+_  ]#YSTW3+O5]0BL+"(RW$IPH X'J2>P'K7T5X-\'VOA331&F);R
M4 SSD<L?0>BCL*S_ (=>%[+0]"CO(OWEW=HKR3,N#@\A1Z 5VX^]1AJ"@KO<
MO-\UGB9NE#2*_$\N^-&DRW.BV>I1*6%I(5DQV5\<_F!^=<%\/O%</A37)9+L
M-]DN8]DC+SM(.0<=^_YU]#W5M#>6TMO/&LD4BE75AD$'J*\,\;_#ZST%9+RQ
MNW$)!80.F[;[!L]/PK/$0E&7M(G5E.*I5J#P5;KM^9N^-_BA;2Z?';>&KV07
M#.&>X1" BCM\PY)XIGPOUKQ!KWB"X:]U*XN+&W@.]7 VEV/';KP37"^$O"P\
M37H@:\-NOJ(MQ_F*^@?#WAW3_#6EK9V$951\SNQRSGU)I47.I/F>PLQ6$P5#
MV%-7D^K6QX)\0M)_L;QK?QJ-L4[?:8L>C\G_ ,>S67H]G-XA\2VMK([227=P
M/-;O@G+'\LU[-\1/!D?B.XLKE;S[++&K(3Y6_<.,=QTY_.J'@7P#'H7B(W\M
M^+IXHF$:^1LVDD#.=Q[9'XU+HMU;=#MI9I36 3?QI6_3<V_'/BRY\&VEB]MI
MT=Q!(3&Q9RH0@#:.!W&?RKB[/QAX6\57<L?BC1[2S)7,=PI)+'N"P (KU?7-
M%L]>TF:PODWPR#GU![$'L17S_P"+O!Z>&95\N]:>-VPH:/!'U.>?R%:8B4X.
M_0\_*(8>O%TY74^C3,_Q1#HL&LO'X?N'FL=H.6SPW< D D=*]<^$2S+X&G,G
M^K:>0Q9],<_KFN \$>!8?%,F^XOGA@1L/''&-S?1B>/R->L^(]&N;7PC%IGA
MW46T8Q.@2:.(2$+SD8)'7UJ<+!N7/T-L[Q4(THX5-MJUVSDOV>?^1'U'_L)R
M?^@)7K,W^ID_W37DWPT\'ZIX2U..%?$CW.FRB2:2R^RA TA4#=NW$YX'Y5W'
MC2WU.[\/F+2=6?2KDRK_ *0D0D.WG(P2.M=Q\N>3_#"UGO?@7XLM;<$SRO<J
M@'4GREXH^&GA/6O$'@6RN]+\?ZCIT*,\36<,0*PL&.1]X=<AO^!5O_#/P=JG
MA+4XH%\2/<Z;*)97L_LH0,Y &[=N)SP/RJKXP\*WG@&:[\2^$=<FTN.YF_?Z
M?Y(EA9L$Y )P![8..Q XH L:[\-=3?29HM>^)][_ &=)A91=QJL;<Y )9\=0
M*RO$5E%X7^(GPU>>Y\_3[>U6T2Y885F'RAO0??4]:L^%O#.H?$DV^L^+]?FU
M"SM'W1Z:D"Q1%O5MIY_+/O7H_B[PCI?C'06TK4(RJ[MT,L8 :%PO#+_+'I0!
MTM>,6U[;WO[3LHMRK?9].,,I']\+DC\,@?A6!:W'C:V\3)X(A\:SB#?Y*W36
M:-(J^Q)W=O[U:EQ\*9O#7B:WO_#WB6XLKCR=DDLEN)GD8_?8DMCYO3'% &IX
MS_Y.!\$?]>\G_M2E^+'_ "4#X>?]A$_^AQUJ_$SPC)J[6/B*QU1]-U3206CF
M2(2;E/.,$CICWZGBH/%'@ZX\4^"=%OKG6I8]9TH?:$OTA&7;J?E!&.54\'C%
M '0?%#_DF/B+_KS;^E)\*_\ DE_A[_KT'\S7&:EI/B;Q'X MK.Z\6R S/,EV
M_P!B3]_&=NU2 1C'/(ZYKH_AEHVI^'],EL+W6WU*UB6)+6,P"(0+\V0,$YSQ
MU]* ,+XC?\ED^'O_ %U?_P!"6O7:\3\4^"]=UKQ:-:'BZ2![.ZD-BGV)6^S#
;/0'<,].XJ?\ LCQ]_P!%'G_\%D?_ ,50!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g882067g1216211413548.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g882067g1216211413548.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  4 &D# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.4</span><table class="report" border="0" cellspacing="2" id="idm45876379548032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 16, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 16,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ ':*069>*NQS     $P(   L
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( !VBD%DWIRWG/ 0  ((0   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    "  =HI!9GZ ;\+$"  #B#   #0              @ & #   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( !VBD%F7BKL<P    !,"   +
M  "  5P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( !VBD%D<.&7J/P$  #P"
M   /              "  440  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M"  =HI!9)!Z;HJT   #X 0  &@              @ &Q$0  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  =HI!999!YDAD!  #/ P
M$P              @ &6$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  #@$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d882067d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cvs-20241216.xsd</File>
    <File>cvs-20241216_lab.xml</File>
    <File>cvs-20241216_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d882067d8k.htm">d882067d8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g882067g1216211413548.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d882067d8k.htm": {
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20241216",
   "dts": {
    "schema": {
     "local": [
      "cvs-20241216.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20241216_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20241216_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d882067d8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-12-16_to_2024-12-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d882067d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-12-16_to_2024-12-16",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d882067d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cvshealth.com//20241216/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-24-279907-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-279907-xbrl.zip
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M=ON*];>8;5_C;F=XW=NM=MS0YS]02P,$%     @ ':*06;EO1EI?!@  OT,
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M&+2R,YKX;1:)K-DK#H8W1% >GK/P3#TQ;\KCL^2.P;1;X15!&*A:!+&934N
MJ@&Z"!J^+;1NY;AV_QB;A4L6<+'DPMPJN4M4O0E?J;5],^%AP^=D>Z0ZW4C4
ML\EKI[AO,FK(XVXYM@J"J0A92= UD78@_X,ORW[DY>8PANB"1N33*IX1T6QB
MBGF=CH?% +=?=P?_N18NY5H=4GDDH+'[M=!;JVD,4*?^^C)4OV/H/4UOCK^$
MVE*13A'>9XW7"':'NU(8EW15"K9KX7+?JA7+$+S #\9(G(:A,B"S_ZXH(\-F
MXV 5Z'04JBSQ/8'N(U JBHM_IO\N/P!=":X9UCZF-1L6]%_@!1']B3J\%E/^
MR%X$?C']-6!OL6.#_BD,#?GGDBT!K\L %Z +X<*.;: *]7HN$#$W3PJNQ8W@
M#Y0%#9_;EFF\!N#+C-FH?Q:+AKY5MR7^TV=W"IV\&NX0M&*E:A(:^$$<AQLN
M$S_ZBRZ;W^BQ*[R&4;";L@W"5B3:&%A46QJ"M!*H4I@W;]JS434 M;TXOA%*
M&Q3$;P+\=DY7;X.R-<YWKSF]"6I'!PE<\WM>*^-PBM_GUAN@:C;K!J)^9V)T
ML^"LX4W#W;R.@"PUP.W77<"T:R'!:<3!J&/=/&FGWR*D39IV _4/09.$L F/
MXQ7+;LK(NK26)'>$;+457A'D F^%(!+!6078+N%,<8N-%U%NVKT;SG<\H@%-
M*)M_5#MN0?VH+LNVS(Y KC#!RR)<$"Y30^+W21YR?6=XVVJY2&ZCOMVPO1%$
MSP=16)AWT>B/"(CK^_OZ&X<JA8XPKF&*[XMTP7J?*A+>J@P4ZT!:"$PE9]#;
M-E$$_H5.4-&_E')%A/L 6'1>QQB4&[0/PTX\XDB4:+<U&&FY5N>C)4>54]+(
MEN/VA@0KM9_:#$>S*4VBVO<X=O.ZVMJ4&>#VZT[;&JL6UJ8F$P>E#D;>?4_3
M2K];.YH&3;N!.A6^_L#MW2:>\=I;\&=)'2%J;YU;+KK :1%"(C-3AE3:F<H6
M&BTB6;=;G'7S?!TLE%O2Y-.(]MR.UT^K$5X>@[&.[NIAKZ5Y!9Q/([;7MW5-
MK=D\QNM[YS$1<S4UOPK^F"S49F3ILX8? BN1Z/05OFI;?&^H^VM\%;)(K&<O
MC.6%(*T$62FDU_A:M&%YD:^NE^*)*W6D_^Y$=HJF?WU!G?D/4$L#!!0    (
M !VBD%F:+^?,M00  'XJ   4    8W9S+3(P,C0Q,C$V7W!R92YX;6S5FEV/
MXC84AN]7VO_@36]::4,FS,=VT# KRLQ4J/,E8-NJ-RN3',"J8T>V&>#?]SC@
MBD"8PG1;Q5SPX?@]?GT>QW%,KCXO,DY>0&DF13N(&R<! 9'(E(E).YCID.J$
ML8!H0T5*N130#I:@@\_7[]]=?0A#<G/7>R0AF1J3ZU84S>?S1CIF0DL^,QA2
M-Q*9120,7?WN\ OY==5<B_2! ]5 ,JH-*/+3C/&TU3QIGL5QL]F(-V4*J(U'
M4FJ@1>)F%'^*;$URT3JY;)TW2>>!W!9A!!FR##:U,E\J-ID:\GWR RE$-U((
MX!R6Y(X)*A)&.1DXRQ])3R0-TN&<]*U,HT\-Z@72QCHJ9^+/EGT;6??D_3N"
M+TRDT$5I.[#I6&=C,5*\(=4$W9Z<1DX4;&H6.Z+Y:2&)+R\OH^)HN;YF5;6Q
M@3CZ_>%^D$PAHR%"0&C)5E/H)C5_JS?-G4>K@ZZ^9BU=1+J729'[ [I%]M:P
MOT)7+;1%8=P,3^/&0J?!M6URE54E.?1A3.SGEWZOU&;RHJ= N9D6@ZK 'S?C
MB\C0A10R6T96%-W(9):!,.ZS(]);89A9]L18JJSH2D"*K+:F"L;M ..&+ICU
M\UT?XWP])HY9YGAB:);E' (2;?0G5SAVA"EJWV-!20 + R*%U(6Q_O^K'E^O
ML*['KDQ*&7"G;\%,0]*8R)<H!5:T:+\4^2ER@S^^=B7.&)V1-HHFIIP#;@>+
M5*Z0TQ'P=E ABKZEH55W^S!A-KPPCS2#0WU5:\OV-BEV5%**3%7BHN+7'83E
MTV!=(\JIPGAA,L49SZG'2F:5J5JW)E_S*U4*JAW@M(FS0$!RQ:3":E@2D)E&
M2S*WYBFWQV ,2D%ZOTK"7K.%4YQ1-10UOS&S#@[5U [7.TXGA\+:$M67TI91
MA^?4&SRK8=;%'BC*>SA++7Z!Y7'GU(ZXOKCV&';8SKS!YJX!0TSCH;3*FOI"
M*OMT;"Z\8_,,Z!4OT>D-+F:/A;0EKC^M+<,.VR=OL+FU5")5+E61VP&F&+IR
MAM/%LBO3(]<:_Q"JOD@/LN\ _^@9X#O&X7&6C4 =1W-35W=TFUX=ITO/. WI
MHI=B&MB8K>Y+WP)M;Y"Z$]QK?(WS],0SG)TTQ23K]0?>(D-\',K* '7'6&G:
M(8S]1-C%KT]J*.?B30 WY9[@V[3LX/ES U[J2G$=?U+/2KXPNVGX%H([,3S!
MN./;L?3M;GW=GV>I#>5_L/SXI6EU!$\X;KEV%/VY>;?S24<!/89;65-?4F6?
MCLVY-VSLOR#\>2K%D3<)N[KZ,MKUZCCYL\GR&_HS(+HRRV9BO4;6A\+:(ZXO
ML3V&'39_-ED&DK.$&28F#W@Q5LQ:.XQ9E;*^P*K<.EK^[)@\*[!##G"U5&S(
MVG\QU=-X?/BT^%J$^M)[S;6CZ,]^RE9O>EK/0/U[EA5QO"%:X7W-]<R?C94!
M)#-K,6Z.ALSP@Y>2N[KZ<MOUZCCYLWLR5-0^9S589B-Y\.5N2U1?0EM&'1Y_
M]D?<$+M=)%,J)G#,0R75VOK"JO;KF/FV#W*;@9K@V/M9R;F9XOR>4W'DLPM[
M0M27X*NV'<C_82OD*MI)S3T6V,<F5T?LFWT($$O^ E!+ P04    "  =HI!9
MEMCLC"43   ?;P  #@   &0X.#(P-C=D.&LN:'1M[3UK=^(XLM_S*W28G9WD
M'!ZV@03(8T^:IJ?922=9DMF9O5_F"%N IHWMD>P ]]??*LDVYF$@"4FZ]Z;/
MZ02CDE0JU5LEY^P?T[%+'IB0W/?.?S++QD^$>;;O<&]X_M/E7;O;_>D?%P=G
MHQ#  -23+8?Q\\(H#(-6I3+M"[<LF5T>^@\5:*A8AE4KQ("1+(6S@,D4>D!E
MO^R+825I60#W?,^+QBGP9#(IJ^&Q@Q.*"O:H % )H)C@=M)OZG+OZT*W255U
M,IO-9D6U)J KD.D$EF%4*]C<IY(EX/:#7("&YQ&C;C@JV_Y8X6Y:YG&*A^3K
ML("1S<KO7Z[N[!$;TQ+W9$@].YTC"D4N1LT*M": 7/HURSS9@'X,D7:8YL&:
M .O!8MGO'WI7<_!P/?P<M!(*ZLF!+\8T!';!D>HEPRI9QYE!2L ."P,E[+%M
MG$:I:J:TA,GYIJ4N41%;G26VC(&/*[HQ!LUG%&3Q K(ZHP[\"GGHLHM&Z9>S
MBOYX<#9F(278O<3^BOC#>:'M>R'SPM(]L&:!V/KIO!"R:5A1PU6@5T4/2 @Y
MZ_O.[.+,X0]$AC.7G1<<+@.7SI#W6>&"G/%I"Z&9B#]SQV&>_@P@UYKQ"7?.
M"Y]5TQ\@<W]T/$!PUF-#+I&PX34= S8>_(0)&&^M;U?83L,>&P!4)-1._($\
M73*MDGG\1^AGG@H7[7_?D<^=RZO[SZ3MB^"LLH#2"HKSV2_'S'/@?_C)I</'
M3JN6RJ</)>ND4;@84%>R;3.O)4X;YA?4[7H.F_["9JO460%X)'D,_'=<:QC5
M5?PJ2SLIV( )4+),PC/JG)94N@'F>DF5IF9")7I>D'P<N.EW(X&+!.562E1:
M>2J=I)4*6_C(J]OGJ,2+75B@>I9^)/2CDNQ63%VU63M0-^G&U%ZEC]S!+P:<
M":(HR-;JG7;WE\7]6>Z,6*\=/X -])WT$52."#_2D%W,<4MZSMOFN#HYL$E+
M.FTZ3V6!.BDUY]2K9!5$!10)_,JH$^Q5HBX?>BT;UL)$8;%]PIUPU&J4Z]P[
MS<"Z;!">CJD8<J^$GUN$1J&??"/X<!1_A<,%R6"HS4LCIEK!;PC2(4(_:&4>
M^WX8^F/U3=\7@'KRC1E,B?1=[I ?U/88A8N__V >&Z=GE2!OHNKVB:PG3Y09
MM@:#D-4%D %L34GR_V4MLY$^#^B8N[/6/1\S2:[9A/3\,?5.5=M$X]WW7>=T
MS?;\>MV][WPD=_>7]YV[?'2,5T+GKM/^M=>][W;NR.7U1]+YO?WY\OKG#FG?
M?/G2O;OKWEP_"T=K'SC^1N4(O-/0]XKD8[E=)I91KS67\)I/VMR!,1?Y89M
MK67,XR<Q9MD L$7>/-5":ID_KBY^1R&=+R;1$>OVJ_E*//7IIO>%G,F >JD:
M&O&0E> ;FX&EG @:%"YR_8>/OAVA^Y#QL9[@/C2:!>W++1KGLPKB=?'./"_
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M<H:M&B ^_E YZ=OW7?5,Q0FB4NZ '&MAA'EQ.N!A%J"7@R*0\A7'(W_/BS6
M<F1PKHR24:5L ;HTNK E5BPPT*K )YEOA_C+NL_2JJ^\0>GJV[[/U;H?F$T3
M#RY>!D@;2JA$_TJ388$(163D/U&$H1V<LD09XP@;I"Q12IODW?.Q3$RYCJ#,
M-J@JU/@:2UU-U)^KI$7_,'=&.@#=M&QP&HG!4?[LLG+'N\>*$EOTUF,8JC_+
M4O[EM[OM![$AP&F7C2!0E88AA0C (2!(#!D (\41[Z/X-9ME4ZT%/@"#:L.
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M3\NJ[8-'*M=LHV#:>V-DY5K>+FQ!_N^= JWXDVOZ>^I=^Y]6]<W_O K3J"F
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MW025E=JKP'RWV&)@VH&B8*H.%&J3==M!R!A QP :&'7 I1,5E3RXS/4=4F@
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M=,#=WGQDFV<G$^VZ/2P4CFV-,(5=31,W&:/(?LS!)"FT!8J]&&_.9D!1*<A
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M01S)9CSNAY+CIXGPT!&WUL&QMWS!T:;US"QOK$M?44[108'A Z+8VL48%JX
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MC6Z]^"<[*];NV4V=KRM[/OYT-UC]_O;$EY^YHCN/;F_SFUN8693>?"2I,EE
M3"[\EOF[7[F2"_@]+]8$+GN]^7QNUF75(PK&KC9NYEI^S Q5*[^NS;.5_B1Z
M[,Y=M_UB)MLBGMVX%7-A>L2Y2V<^;FJJZ_(MV]^P@#WP^()%75;-P@P] AI<
MBQ<P=6DP%AC/X?)=5;7BSXI%#>+,%P)_!+HRR+>*!#JP@K :.U #P_^; %!+
M 0(4 Q0    ( !VBD%D@1%FK/0,  $T+   0              "  0    !C
M=G,M,C R-#$R,38N>'-D4$L! A0#%     @ ':*06;EO1EI?!@  OT,  !0
M             ( !:P,  &-V<RTR,#(T,3(Q-E]L86(N>&UL4$L! A0#%
M  @ ':*069HOY\RU!   ?BH  !0              ( !_ D  &-V<RTR,#(T
M,3(Q-E]P<F4N>&UL4$L! A0#%     @ ':*069;8[(PE$P  'V\   X
M         ( !XPX  &0X.#(P-C=D.&LN:'1M4$L! A0#%     @ ':*06? #
M$"AW%0  )8<  !$              ( !-"(  &0X.#(P-C=D97@Y.3$N:'1M
M4$L! A0#%     @ ':*065N_A/C/&   +LT  !$              ( !VC<
M &0X.#(P-C=D97@Y.3(N:'1M4$L! A0#%     @ ':*064JI+TT1!0  H 4
M !D              ( !V%   &<X.#(P-C=G,3(Q-C(Q,30Q,S4T."YJ<&=0
52P4&      < !P## 0  (%8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d882067d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20241216.xsd" xlink:type="simple"/>
    <context id="duration_2024-12-16_to_2024-12-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2024-12-16</startDate>
            <endDate>2024-12-16</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-12-16_to_2024-12-16"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-278">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-12-16_to_2024-12-16"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-289">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-290">2024-12-16</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-291">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-292">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-293">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-294">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-295">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-296">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-297">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-298">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-299">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-300">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-301">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-302">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-303">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-304">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-305">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-306">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-12-16_to_2024-12-16" id="ixv-307">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
